Matches in Wikidata for { <http://www.wikidata.org/entity/Q47652109> ?p ?o ?g. }
- Q47652109 description "2018 nî lūn-bûn" @default.
- Q47652109 description "2018年の論文" @default.
- Q47652109 description "2018年学术文章" @default.
- Q47652109 description "2018年学术文章" @default.
- Q47652109 description "2018年学术文章" @default.
- Q47652109 description "2018年学术文章" @default.
- Q47652109 description "2018年学术文章" @default.
- Q47652109 description "2018年学术文章" @default.
- Q47652109 description "2018年學術文章" @default.
- Q47652109 description "2018年學術文章" @default.
- Q47652109 description "2018年學術文章" @default.
- Q47652109 description "2018年學術文章" @default.
- Q47652109 description "2018年學術文章" @default.
- Q47652109 description "2018년 논문" @default.
- Q47652109 description "article científic" @default.
- Q47652109 description "article scientific" @default.
- Q47652109 description "article scientifique" @default.
- Q47652109 description "articol științific" @default.
- Q47652109 description "articolo scientifico" @default.
- Q47652109 description "artigo científico" @default.
- Q47652109 description "artigo científico" @default.
- Q47652109 description "artigo científico" @default.
- Q47652109 description "artikel ilmiah" @default.
- Q47652109 description "artikull shkencor" @default.
- Q47652109 description "artikulong pang-agham" @default.
- Q47652109 description "artykuł naukowy" @default.
- Q47652109 description "artículo científico publicado en 2018" @default.
- Q47652109 description "artículu científicu" @default.
- Q47652109 description "bilimsel makale" @default.
- Q47652109 description "bài báo khoa học" @default.
- Q47652109 description "naučni članak" @default.
- Q47652109 description "scienca artikolo" @default.
- Q47652109 description "scientific article published on 15 January 2018" @default.
- Q47652109 description "scientific article published on 15 January 2018" @default.
- Q47652109 description "scientific article published on 15 January 2018" @default.
- Q47652109 description "teaduslik artikkel" @default.
- Q47652109 description "tieteellinen artikkeli" @default.
- Q47652109 description "tudományos cikk" @default.
- Q47652109 description "vedecký článok" @default.
- Q47652109 description "vetenskaplig artikel" @default.
- Q47652109 description "videnskabelig artikel" @default.
- Q47652109 description "vitenskapelig artikkel" @default.
- Q47652109 description "vitskapeleg artikkel" @default.
- Q47652109 description "vědecký článek" @default.
- Q47652109 description "wetenschappelijk artikel" @default.
- Q47652109 description "wissenschaftlicher Artikel" @default.
- Q47652109 description "επιστημονικό άρθρο" @default.
- Q47652109 description "мақолаи илмӣ" @default.
- Q47652109 description "наукова стаття, опублікована в січні 2018" @default.
- Q47652109 description "научна статия" @default.
- Q47652109 description "научная статья" @default.
- Q47652109 description "научни чланак" @default.
- Q47652109 description "научни чланак" @default.
- Q47652109 description "գիտական հոդված հրատարակված 2018 թվականի հունվարի 15-ին" @default.
- Q47652109 description "מאמר מדעי" @default.
- Q47652109 description "مقالة علمية نشرت في 15 يناير 2018" @default.
- Q47652109 description "১৫ জানুয়ারি ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q47652109 description "บทความทางวิทยาศาสตร์" @default.
- Q47652109 description "სამეცნიერო სტატია" @default.
- Q47652109 name "Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial." @default.
- Q47652109 name "Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial." @default.
- Q47652109 type Item @default.
- Q47652109 label "Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial." @default.
- Q47652109 label "Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial." @default.
- Q47652109 prefLabel "Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial." @default.
- Q47652109 prefLabel "Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial." @default.
- Q47652109 P1433 Q47652109-77F68CD0-7511-4701-980F-FE95CFF2DD0E @default.
- Q47652109 P1476 Q47652109-C7C8E7DD-5B05-4A9E-9D9A-31AAFED7FCDB @default.
- Q47652109 P2093 Q47652109-033B4977-BB84-4C9C-9842-7A176B5BDD28 @default.
- Q47652109 P2093 Q47652109-1597ABE2-F76E-4BA3-948E-8C5B81FB8C88 @default.
- Q47652109 P2093 Q47652109-4811F689-F5BF-4472-8C4E-B782C7345744 @default.
- Q47652109 P2093 Q47652109-9241B7D9-4223-4486-A56F-FBA0C51976C4 @default.
- Q47652109 P2093 Q47652109-A06100D2-2798-4759-B96B-08B652AFECB1 @default.
- Q47652109 P2093 Q47652109-CCB2AF97-8816-4175-827B-BC0DC5336F67 @default.
- Q47652109 P304 Q47652109-5B4AA822-C69A-46E4-AD26-A8F466C1928D @default.
- Q47652109 P31 Q47652109-A7A6FC8C-F5C0-433B-B483-479A40F7E84B @default.
- Q47652109 P356 Q47652109-B05BAEAD-0963-4D5A-9B28-D1DBF416BAEC @default.
- Q47652109 P407 Q47652109-6AF8B2FF-3C97-4A85-9995-B05BF0D846B5 @default.
- Q47652109 P433 Q47652109-AF3CF9B1-FE2F-4855-B1B0-0A6D08760D8A @default.
- Q47652109 P478 Q47652109-1594BA9C-606F-41CF-A615-75EC08848F2B @default.
- Q47652109 P50 Q47652109-0C5A5FED-FE7C-495E-B326-21149E2F644E @default.
- Q47652109 P50 Q47652109-15FD4E56-70ED-4498-951C-34A1498B37C2 @default.
- Q47652109 P50 Q47652109-2455F856-EB23-4638-84EE-948F05E5A255 @default.
- Q47652109 P50 Q47652109-38E1FBF4-E3D9-4B98-9CE7-2478CE88C695 @default.
- Q47652109 P50 Q47652109-3FF0F493-D91C-4956-9F2A-C54B55B3868A @default.
- Q47652109 P50 Q47652109-77972F7F-02B0-40A8-A8E9-0487A25C3EB1 @default.
- Q47652109 P50 Q47652109-87A92604-57DC-44B5-BDB8-6BDB478F6ACD @default.
- Q47652109 P50 Q47652109-A8CFE7F6-8C19-46B1-83FB-48B6DA54A9C7 @default.
- Q47652109 P50 Q47652109-BC862CD0-9BE2-4250-BA61-B95DEC2D2FD0 @default.
- Q47652109 P50 Q47652109-CAB42219-501F-4F83-960F-C8ED655244CB @default.
- Q47652109 P50 Q47652109-D2611FED-4559-4E53-AD4E-C0688DB48BDB @default.
- Q47652109 P50 Q47652109-F27EE340-1684-4830-B7C0-97ECDF640A74 @default.
- Q47652109 P50 Q47652109-FF2B16F1-E4D7-453C-8A32-B02346D06B0D @default.
- Q47652109 P577 Q47652109-C9D5BD60-59D3-4D82-A79D-AE62CC7B30E1 @default.
- Q47652109 P698 Q47652109-E15C0FAB-F12E-4126-9B4D-6DC0890059F9 @default.
- Q47652109 P921 Q47652109-5FE337A0-6B5E-4988-87E6-C6D3DD6E651C @default.
- Q47652109 P356 J.JAAD.2018.01.016 @default.
- Q47652109 P698 29353025 @default.
- Q47652109 P1433 Q15757046 @default.
- Q47652109 P1476 "Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial." @default.